Therapeutic Area | MeSH |
---|---|
mental disorders | D001523 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
AZSTARYS | Commave Therapeutics | N-212994 RX | 2021-05-07 | 3 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
10% methyl salicylate pain relief patch | C200263 | 2024-06-27 |
1st medxpatch | C200263 | 2024-10-31 |
365 whole foods market anticavity/antigingivitis mouthwash | OTC monograph not final | 2022-05-12 |
5kind dmso | C200263 | 2025-08-04 |
701 dieda zhengtong yaogao medicated | OTC monograph not final | 2019-11-13 |
701 dieda zhengtong yaogao medicated plaster | OTC monograph not final | 2014-06-26 |
abejas y viboras roll on | C200263 | 2025-07-22 |
absolut skin spf 50 moisturizing sunscreen | C200263 | 2025-06-19 |
advanced antiseptic citrus | C200263 | 2025-02-20 |
advanced citrus antiseptic | C200263 | 2025-01-10 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
attention deficit disorder with hyperactivity | EFO_0003888 | D001289 | F90 |
Expiration | Code | ||
---|---|---|---|
DEXMETHYLPHENIDATE HYDROCHLORIDE / SERDEXMETHYLPHENIDATE CHLORIDE, AZSTARYS, COMMAVE THERAP | |||
2026-05-07 | NCE |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 62 | 5 | — | 3 | 14 | 83 |
Anesthesia | D000758 | — | — | 7 | 4 | 10 | 28 | 31 | 78 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 24 | 16 | 8 | 5 | 10 | 61 |
Neoplasms | D009369 | — | C80 | 31 | 11 | 2 | 4 | 8 | 54 |
Postoperative pain | D010149 | — | G89.18 | 2 | 4 | 2 | 15 | 20 | 42 |
Emergence delirium | D000071257 | — | — | 1 | 1 | 2 | 16 | 23 | 42 |
Prostatic neoplasms | D011471 | — | C61 | 9 | 20 | 7 | 2 | 3 | 37 |
Delirium | D003693 | — | R41.0 | 1 | 1 | 2 | 13 | 20 | 37 |
Pain | D010146 | EFO_0003843 | R52 | 8 | 12 | 3 | 3 | 11 | 36 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 9 | 14 | — | 4 | 10 | 32 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 8 | 7 | 2 | — | 2 | 15 |
Lymphoma | D008223 | — | C85.9 | 9 | 8 | 1 | — | — | 14 |
Glioblastoma | D005909 | EFO_0000515 | — | 10 | 2 | 1 | — | 1 | 12 |
Myeloid leukemia acute | D015470 | — | C92.0 | 9 | 4 | 1 | — | — | 11 |
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | 3 | 2 | 5 | — | 2 | 11 |
Myeloid leukemia | D007951 | — | C92 | 4 | 4 | 2 | — | 2 | 10 |
Cough | D003371 | — | R05 | 1 | 4 | 3 | — | 2 | 10 |
Basal cell neoplasms | D018295 | — | — | 1 | 3 | 5 | — | 3 | 10 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 3 | 4 | 3 | — | 2 | 9 |
Dyslipidemias | D050171 | — | — | — | 4 | 3 | — | 2 | 9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 7 | 11 | — | — | 3 | 21 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 2 | 9 | — | — | — | 10 |
Gastroparesis | D018589 | EFO_1000948 | K31.84 | 3 | 6 | — | — | — | 9 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 4 | 5 | — | — | 1 | 8 |
Myelodysplastic syndromes | D009190 | — | D46 | 6 | 6 | — | — | — | 8 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 5 | 4 | — | — | — | 8 |
Multiple myeloma | D009101 | — | C90.0 | 6 | 2 | — | — | — | 8 |
Glioma | D005910 | EFO_0000520 | — | 5 | 3 | — | — | 1 | 8 |
Alcoholism | D000437 | EFO_0003829 | F10.1 | 3 | 2 | — | — | 3 | 8 |
Obstructive lung diseases | D008173 | — | — | 3 | 4 | — | — | 1 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | 3 | — | — | — | 3 | 6 |
Aging | D000375 | GO_0007568 | R41.81 | 1 | — | — | — | 4 | 5 |
Hepatic insufficiency | D048550 | — | — | 3 | — | — | — | — | 3 |
Pick disease of the brain | D020774 | EFO_0003096 | G31.01 | 1 | — | — | — | 2 | 3 |
Hearing loss | D034381 | EFO_0004238 | H91.9 | 2 | — | — | — | 1 | 3 |
Overweight | D050177 | — | E66.3 | 1 | — | — | — | 2 | 3 |
Addictive behavior | D016739 | EFO_0004347 | — | 2 | — | — | — | 1 | 3 |
Pharmacokinetics | D010599 | — | — | 3 | — | — | — | — | 3 |
Heart disease risk factors | D000082742 | — | — | 3 | — | — | — | — | 3 |
Vasoconstriction | D014661 | — | — | 3 | — | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | — | — | 6 | 6 |
Deglutition disorders | D003680 | — | R13.1 | — | — | — | — | 3 | 3 |
Brain ischemia | D002545 | EFO_0003883 | I67.82 | — | — | — | — | 3 | 3 |
Trigger finger disorder | D052582 | — | M65.3 | — | — | — | — | 3 | 3 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 3 | 3 |
Surgical blood loss | D016063 | — | — | — | — | — | — | 3 | 3 |
Hypothermia | D007035 | — | T68 | — | — | — | — | 3 | 3 |
Dental plaque | D003773 | — | — | — | — | — | — | 3 | 3 |
Cerebral palsy | D002547 | — | G80 | — | — | — | — | 2 | 2 |
Operative surgical procedures | D013514 | — | — | — | — | — | — | 2 | 2 |
Drug common name | Dexmethylphenidate |
INN | dexmethylphenidate |
Description | Dexmethylphenidate is a methyl phenyl(piperidin-2-yl)acetate in which both stereocentres have R configuration. It is the active enantiomer in the racemic drug methylphenidate. It has a role as an adrenergic agent. It is an enantiomer of a methyl (S)-phenyl[(S)-piperidin-2-yl]acetate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1 |
PDB | — |
CAS-ID | 40431-64-9 |
RxCUI | — |
ChEMBL ID | CHEMBL827 |
ChEBI ID | 51860 |
PubChem CID | 154101 |
DrugBank | DB06701 |
UNII ID | M32RH9MFGP (ChemIDplus, GSRS) |